#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metachromatic leukodystrophy Soft tissue necrosis Amyloidosis Fibrosarcoma Acute graft versus host disease Alpha-1 antitrypsin deficiency Autoimmune hepatitis Pituitary-dependent Cushing's syndrome Prodromal Alzheimer's disease Emphysema Lupus nephritis Adrenogenital syndrome Dedifferentiated liposarcoma Metastases to central nervous system Autoinflammation with infantile enterocolitis More trials…

    Learn about Rare Diseases

    Prader-Willi syndrome – Life with Disease Cystic fibrosis – Basic Information Angiosarcoma Idiopathic pulmonary fibrosis – Treatment Small intestine leiomyosarcoma – Life with Disease Antithrombin III deficiency – Life with Disease Carcinoid syndrome – Basic Information Glycogen storage disease type II – Treatment Burkitt’s lymphoma Hereditary angioedema – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Etravirine Terbinafine Choriogonadotropin Alfa Roxadustat Tucidinostat Pacritinib Gen1055 ELTANEXOR Damoctocog Alfa Pegol Dersimelagon Phosphate Mva-209-Fsp-B2 2-DEOXY-D-GLUCOSE Ceftriaxone Sodium ADX-324 Gozetotide Alf-18 Cart 19/22 T Cells Certolizumab Pegol Elebsiran SAROGLITAZAR HEMIMAGNESIUM Sapropterin Dihydrochloride More therapies…

    Learn about Your Condition

    Hereditary ataxia Genital herpes Perinatal depression Tubulointerstitial nephritis Hypoparathyroidism Dyspnoea Hypervolaemia Ewing's sarcoma Colorectal cancer stage III Cervix carcinoma stage IV Lower limb fracture Hepatic angiosarcoma Neurofibromatosis Epithelioid sarcoma Juvenile idiopathic arthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Dermatologija Bartenjev

Dermatologija Bartenjev

Finzgarjeva ulica 4, Ljubljana, 1000, Slovenia

Want to learn more about this study or check if you can participate? Contact us.

  • A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Cagrilintide
    • Dapagliflozin
    • Metformin
    Bulgaria Croatia Czechia Denmark Finland Germany +9

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!